iiinova — where your digital self keeps evolving

MaxCyte

@maxcyte.com

Helping teams engineer cells and move to the clinic faster—through scalable platforms, risk assessment, and real partnership. maxcyte.com

Posts Replies Media

MaxCyte @maxcyte.com · 28/05/2026

On Tuesday, MaxCyte CEO Maher Masoud sat down with Big4Bio for a wide-ranging conversation on the state of the industry, his journey to MaxCyte, and our “obsession with customer success.” 🌟 Read it in full ➡️ ttps://bit.ly/4f9mITM

030

MaxCyte @maxcyte.com · 19/05/2026

Great conversations at PEGS Boston last week around biologics discovery challenges. One theme we heard often: balancing throughput with reproducibility in screening workflows. Thanks to everyone who stopped by to see the ExPERT DTx™ and GTx®. What’s been hardest to scale in your workflows lately?

000

MaxCyte @maxcyte.com · 07/05/2026

It's day 2 of ISCT, International Society for Cell & Gene Therapy in Dublin, which means the return of the green sample! 🇮🇪 👋 Stop by booth 2904, say hi to Ben Cavagan and Linda Meggiolaro, and check out the ExPERT GTx® and DTx™ in action.

000

MaxCyte @maxcyte.com · 30/04/2026

Our CEO Maher Masoud sat down with @pharmexec.bsky.social to discuss what it takes to scale cell and gene therapies. One point that stood out: avoiding constant re-optimization when moving from R&D to commercial. Curious, how are other teams handling that transition? 👀 bit.ly/4cT8pzE

000